Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy

AIMS: Exogenous atrial natriuretic peptide (ANP) may be a logical treatment for heart failure (HF) patients with ANP deficiency. Lower ANP concentrations may result from HF with preserved ejection fraction (HFpEF), which also results in lower brain natriuretic peptide levels in HFpEF relative to HF...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Matsumoto, Shingo, Nakazawa, Gaku, Ohno, Yohei, Ishihara, Mai, Sakai, Katsuaki, Nakamura, Norihito, Murakami, Tsutomu, Natsumeda, Makoto, Kabuki, Takayuki, Shibata, Atsushi, Kida, Keisuke, Konishi, Masaaki, Ishii, Shunsuke, Ikeda, Takanori, Ikari, Yuji
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754892/
https://ncbi.nlm.nih.gov/pubmed/33037750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13042
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars